Nicole Scobie
Publications by Year
Research Areas
CAR-T cell therapy research, Childhood Cancer Survivors' Quality of Life, Neuroblastoma Research and Treatments, Pharmaceutical studies and practices, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies(2021)49 cited
- → ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children(2019)47 cited
- → ACCELERATE – Five years accelerating cancer drug development for children and adolescents(2022)47 cited
- → Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents(2020)43 cited
- → Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer(2021)37 cited
- → Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas(2022)23 cited
- → Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer(2017)21 cited
- → Setting international standards for patient and parent involvement and engagement in childhood, adolescent and young adult cancer research: A report from a European Collaborative Workshop(2021)19 cited
- → Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed(2023)18 cited
- → Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE(2021)17 cited